Related Experiment Video
Updated: Apr 8, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
1.4K
Targeting the inflammasome in rheumatic diseases
Sara S McCoy1, Jasmine Stannard2, J Michelle Kahlenberg1
1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich.
Summary
The inflammasome protein complex is crucial in rheumatic diseases. Therapies targeting the inflammasome and its cytokines aim to reduce inflammation and autoimmune responses.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- The inflammasome is a key protein complex involved in cellular functions and immune responses.
- Activation of the inflammasome leads to the release of pro-inflammatory cytokines like interleukin (IL)-1β and IL-18.
- Inflammasome activation is implicated in the pathogenesis of various rheumatic diseases, including autoimmune, inflammatory, and autoinflammatory syndromes.
Purpose of the Study:
- To review recent advancements in understanding the inflammasome's role in rheumatic diseases.
- To discuss therapeutic strategies targeting the inflammasome and its downstream cytokines.
Main Methods:
- Literature review of recent research on inflammasome function in rheumatic diseases.
- Analysis of current and emerging therapies that modulate inflammasome activity.
Main Results:
- The inflammasome plays a significant role in the inflammatory processes underlying numerous rheumatic conditions.
- Targeting the inflammasome and its associated cytokines offers potential therapeutic benefits.
Conclusions:
- Understanding inflammasome pathways is critical for developing novel treatments for rheumatic diseases.
- Therapies aimed at the inflammasome complex and its cytokines show promise in managing inflammation and autoimmune processes in rheumatology.
More Related Videos
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
775
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
775
01:23Rheumatic Heart Disease I: Introduction
904
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
904
01:20The JAK-STAT Signaling Pathway
14.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
14.0K
01:24T Cell Types and Functions
3.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K
01:21Rheumatic Heart Disease III: Medical Management
511
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
511
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
698
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
698